New allergy relief, over the counter

Watson, Traci; Wiener, Leonard
January 1997
U.S. News & World Report;1/20/97, Vol. 122 Issue 2, p70
Reports the US Food and Drug Administration approved, in January 1997, the over-the-counter use of cromolyn sodium. The drug, called Nasalcrom, as the first over-the-counter drug than can both treat and prevent symptoms of allergic rhinitis; How to use the drug for best effect; Limitations of the drug; Availability date.


Related Articles

  • Bronchodilator effect of sodium cromoglycate and its clinical implications. Chung, J.T.N.; Jones, R.S. // British Medical Journal;10/27/1979, Vol. 2 Issue 6197, p1033 

    Examines the efficacy of sodium cromoglycate (SCG) for the treatment of children with asthma. Comparison between SCG and salbutamol with placebo; Measurement of peak expiratory flow rate before exercise; Evaluation of the bronchodilator action of SCG.

  • Sodium cromoglycate in proctitis and ulcerative colitis. Allan, R.N. // British Medical Journal (Clinical Research Edition);1/9/1982, Vol. 284 Issue 6309, p70 

    Investigates the efficacy of sodium cromoglycate in treating symptomatic proctitis and ulcerative colitis. Association between sodium cromoglycate and improved sigmoidoscopic and rectal biopsy arrangements; Confirmation of the relapse rate; Effectiveness of desensitization.

  • Prescription nasal spray specifically OK'd for OTC allergy...  // FDA Consumer;Apr97, Vol. 31 Issue 3, p5 

    Focuses on Nasalcrom, a nasal spray approved by the Food and Drug Administration for preventing and treating nasal allergy symptoms. Prescription on the use of the spray; Drugs to be use in conjunction with Nasalcrom in the first part of the therapy; Side effects of the drug.

  • New treatment for ulcerative colitis?  // British Medical Journal;1/3/1976, Vol. 1 Issue 6000, p2 

    Examines the latest treatment for ulcerative colitis. Relation of ulcerative proctitis to ulcerative colitis; Usefulness of disodium cromoglycate (DSCG) in treating the disease; Effect of using the DSCG and the double-blind crossover method.

  • The Evaluation of Concentration - In-Vitro Release Relationship for Topical Semisolid Formulations of Sodium Cromoglycate. STĂNESCU, ANA ANDREEA // Current Health Sciences Journal;2015, Vol. 41 Issue 4, p368 

    The aim of the study was to evaluate the concentration - in-vitro release relationship for topical semisolid formulations of sodium cromoglycate. Materials / Methods. According to usual pharmaceutical compounding practice, commercially available cosmetic emulsions were used as vehicles for...

  • Choosing Therapy for Childhood Asthma. Holgate, Stephen T.; Frew, Anthony J. // New England Journal of Medicine;12/04/97, Vol. 337 Issue 23, p1690 

    Editorial. Focuses on choosing a therapy for childhood asthma. The availability of inhaled corticosteroids, cromolyn sodium or nedocromil sodium, beclomethasone dipropionate and salmeterol; Other options, such as environmental interventions; Reference to work by Simons et al in same issue.

  • Inhaled cromolyn for cough caused by ACE inhibitors.  // American Family Physician;5/1/1995, Vol. 51 Issue 6, p1585 

    Highlights the study conducted by Hargreaves and Benson on the usefulness of inhaled cromolyn in patients with cough caused by treatment with angiotensin converting enzyme (ACE) inhibitors, published in the January 1995 issue of the `Lancet'. Baseline frequency and severity of cough; Median...

  • Preventive effect of 2 and 10 mg of sodium cromoglycate on exercise-induced bronchoconstriction. Storm van's Gravesande, Karin; Mattes, Jörg; Großklauß, Elke; Zurmühl, Andreas; Moseler, Michael; Kühr, Joachim // European Journal of Pediatrics;2000, Vol. 159 Issue 10, p759 

    Abstract This double-blind, randomised and cross-over study was designed to compare the preventive effect against exercise-induced bronchoconstriction (EIB), defined as the percentage decrease in FEV[sub 1] is greater than or equal to 15% after 6 min of exercise, of 2 mg and 10 mg of sodium...

  • Nasal sprays for allergies. Bowling, Ernest L. // Optometry Times;May2014, Vol. 6 Issue 5, p9 

    The article discusses managing allergic conjunctivitis (AC) with allergic rhinitis (AR). It offers a brief explanation on why the correlations between the two conditions were reported to reach as much as 70% among patients. Therapeutic approaches discussed include prevention and avoidance of...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics